The expression and severity of experimental giant cell myocarditis in rats are strongly influenced by genetic factors, including major histocompatibility complex genes.
Answers are grounded in this paper and cite their sources.
Genetic background dictates rat strain susceptibility to giant cell myocarditis; leaves open MHC relevance in human disease.
Immunogenetic mechanisms may be involved in the pathogenesis of myocarditis and dilated cardiomyopathy. The present study investigated the incidence, histopathology and histocompatibility characteristics of experimental giant cell myocarditis in various strains of rats. Experimental giant cell myocarditis was induced by immunization with porcine cardiac myosin in Lewis (RT-1(l)), Dahl (DIR/Eis) (RT-1(l)), Fisher (RT-1(lv 1)) rats, but not in Dahl (DIS/Eis) (RT-1(l)) or Brown Norway (RT-1(n)). Myocarditis was most severe in the Lewis rats and their heart weight/body weight ratio was significantly higher than that of control rats immunized with Freund's complete adjuvant alone. In conclusion, this study provides evidence that the expression and severity of experimental giant cell myocarditis may be determined mainly by genetic factors, including both major histocompatibility complex genes as well as other genes, which may be controlled by an immune mechanism.
No takes yet. Share an insight, caveat, or question.
Shioji et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: